Outcome measures in ABA treatment plans: what CMS, payers and the 2026 guidelines ask for

Payers ask for standardized outcome measures and may mean different things, so sort your tools first.

• Norm-referenced scales compare a child with age norms. CASP’s evidence resource says the measures most often used in ABA outcome research for young children are standardized, norm-referenced scales, including the Vineland and the CARS, and the meta-analysis it describes required each to show validity, reliability and norming¹. Aetna’s guide likewise calls for validated tools with standardized developmental norms and states impairment in standard deviations below the mean².
• Skills and curriculum assessments tell you which skills to teach next. CMS’s example list of outcome instruments is made of them, including the ABLLS-R and the VB-MAPP, a tool the toolkit says guides curriculum and goal development and also evaluates progress³¹⁶. A 2023 systematic review of criterion-referenced ABA assessments found conflicting support for them and a mismatch between their use and the validity evidence behind them⁴.
• Your own session data are the graphs and goal status behind daily decisions. CMS says states should not allow provider-created outcome measures³, and Florida requires a data table and graph for each behavior under treatment⁶.

The toolkit also separates outcome evaluations, which use tools designed to assess progress toward goals, from diagnostic evaluations³. It files the Vineland-3 and the ABAS-3 among adaptive-behavior tools that support diagnosis³, while Florida repeats the Vineland-3 as a core instrument at reassessment and TRICARE lists it as a required outcome measure⁶¹⁰. Choose instruments that are sensitive to change⁵, and read scores beside goal data: CASP notes that children can make clinically meaningful gains without reaching the non-clinical range¹.

The CASP and APBA ASD Assessment Guidelines for Behavior Analysts, which APBA’s CEO called recently published in a note dated May 7, 2026⁸, aim to help you select, design and administer multimodal assessments of core symptoms and autism characteristics, adaptive functioning, well-being and quality of life, and co-occurring conditions⁷. CASP adds a companion repository of tools and states that listing an instrument is not an endorsement⁷. The guidelines and the repository are released after a user attestation, so this article relies on CASP’s public description. Read the document before relying on any summary⁷.

The CMS toolkit of August 2026 is written for states and is more specific. It calls it best practice for states to require at least one standardized outcome assessment instrument and not to allow provider-created ones³. It also asks that plan updates use established measures and that plans include outcomes a standardized instrument can measure³. CMS says the toolkit creates no new federal requirements⁹.

This sample is not a national list, and each plan’s own form and contract govern. For the first report, see our initial assessment guide.

There is no national clock. The toolkit says clinical guidance is lacking on which evaluations to complete and how often to reevaluate, and it tells states to set specific time points³. So the strictest clock in your caseload sets your calendar: Florida’s 6 and 12 months, TRICARE East’s 6 months and yearly cycle, Aetna’s 6 months⁶¹⁰². Watch the windows too. TRICARE East says to complete outcome measures no earlier than 90 days before they are due¹⁰.

In force in Florida: the December 2024 coverage policy, effective February 10, 2025 and still the latest adopted version of Rule 59G-4.125 on October 16, 2026⁶¹⁵. It requires services to follow CASP’s current practice standards but predates the assessment guidelines, so ask your plan how it treats them⁶. TRICARE East’s pages date from March and June 2026 and Aetna’s guide from 2026, but each plan’s own benefits and contract govern²¹⁰¹². The toolkit creates no new federal requirements⁹.

What may change: AHCA staff told the ABA Task Force on October 5 that current policy requires two norm-referenced tools, the Vineland-3 and BASC-3, and floated requiring a selection of skill-based tools for each behavior assessment, with the ABLLS-R and VB-MAPP among the examples, and creating a standardized treatment plan template¹⁶. A September 28 presentation to the task force covered measuring quality through standardized, individualized patient outcomes, the minutes record no approved recommendation, and recommendations are due December 31, 2026¹⁷¹⁸. This article is not legal, clinical or billing advice: confirm instruments and dates with the plan, the BACB or an attorney.